inhibitory activities against fattyacidamidehydrolase. Among of them, 13 compounds inhibitfattyacidamidehydrolase by 50% at the concentration of 100 μM. Of these compounds, the most active one is compound 9, which inhibitfattyacidamidehydrolaseactivity 98.35% at the concentration of 100 µM. Comparative molecular field analysis analyzes were performed based on obtained biologicalactivities data
Five fatty acid amides, termitomycamides A to E (1 to 5), were isolated from the giant edible mushroom Termitomyces titanicus. The structures of 1-5 were determined by the interpretation of spectral data and/or synthesis. Compounds 2 and 5 showed protective activity against endoplasmic reticulum stress-dependent cell death.
Inhibitors of anthrax lethal factor
作者:Brandon D. Gaddis、Larisa V. Avramova、Jean Chmielewski
DOI:10.1016/j.bmcl.2007.05.089
日期:2007.8
An inhibitor of anthrax lethal toxin mediated cell death (1) was identified by a medium throughput cell-based screen. This compound was determined to specifically inhibit anthrax lethal factor (LF), and subsequent SAR studies produced an even more potent inhibitor (4). Mechanistic studies identified these agents as uncompetitive inhibitors of LF with K-i values of 3.0 and 1.7 mu M, respectively, with good cell potency and low cytotoxicity. (c) 2007 Elsevier Ltd. All rights reserved.
Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT<sub>2C</sub> Receptor and Dual 5-HT<sub>2C</sub>/5-HT<sub>2A</sub> Receptor Modulators
作者:Jianping Chen、Erik J. Garcia、Christina R. Merritt、Joshua C. Zamora、Andrew A. Bolinger、Konrad Pazdrak、Susan J. Stafford、Randy C. Mifflin、Eric A. Wold、Christopher T. Wild、Haiying Chen、Noelle C. Anastasio、Kathryn A. Cunningham、Jia Zhou
DOI:10.1021/acs.jmedchem.3c00908
日期:2023.7.27
HUMAN GUT MICROBIOME-DERIVED BIOSYNTHETIC ENZYMES FOR PRODUCTION OF FATTY ACID AMIDES
申请人:Massachusetts Institute of Technology
公开号:US20200299738A1
公开(公告)日:2020-09-24
Disclosed herein, in some embodiments, are vectors encoding biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes), engineered cells comprising the vectors, and methods of using biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes) to produce fatty acid amides.